Flat Medical Closes Series C Financing for Global Expansion

Taiwan-based Flat Medical has closed Series C financing led by Taiwania Capital, followed by ITIC (Industrial Technology Investment Corporation), Fidelitas Corporation, and several individual investors, to accelerate its growth and expand its presence in key markets across the United States, Europe, and Asia-Pacific (APAC).

Flat Medical’s expansion plan includes increased efforts to enter the key markets in the United States, Europe and APAC where there is a growing demand for advanced medical solutions for patient safety. The company is actively engaging with key stakeholders in the medical industry, forging partnerships with clinicians and healthcare facilities, and obtaining regulatory approvals to launch EpiFaith and EpiFaith CV in new markets.

Flat Medical’s flagship products, EpiFaith and EpiFaith CV, have revolutionised safety measures for epidural and central line procedures and have been widely acclaimed by medical professionals and healthcare institutions worldwide. By integrating cutting-edge technology and a patient-centred approach, Flat Medical’s solutions have significantly reduced complications and improved patient outcomes in critical medical procedures.

Flat Medical is working with several top-tier academic hospitals to gather real-world evidence for its EpiFaith® technology in epidural and central line placement, with the goal of having the products included in clinical guidelines in the near future. The company is also working with sales and marketing partners to build a trusted brand with a spirit of innovation and reliable service.